Hypothyroidism as an Independent Predictor of 30‐day Readmission in Head and Neck Cancer Patients
Sarah C. Nyirjesy(The Ohio State University), Catherine T. Haring(The Ohio State University), Ryan T. Judd(The Ohio State University), Hilary McCrary(The Ohio State University), Nolan B. Seim(The Ohio State University Wexner Medical Center), Stephen Y. Kang(The Ohio State University Wexner Medical Center), Hannah N. Kuhar(The Ohio State University), Janice L. Farlow(Indiana University Health), Songzhu Zhao(West Virginia University), James W. Rocco(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 9
Related Papers
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
|Cell|2017|2.6k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Head and neck cancer
|The Lancet|2021|829
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
|Journal of the National Comprehensive Cancer Network|2022|532